<!DOCTYPE HTML>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>IV Endocrine, nutritional and metabolic diseases (E4_)</title>
</head>
<body>
<br>
<div><a href="taglist.html">Back to all tags listing
</a>
</div>
<h1>#E4: IV Endocrine, nutritional and metabolic diseases (E4_)</h1>
<span style="margin-left:0em; font-size:160%;"><a href="E4_ENDONUTRMET.html">[1] E4_ENDONUTRMET</a>: Endocrine, nutritional and metabolic diseases (ICD-10: E)<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_THYROID.html">[2] E4_THYROID</a>: Disorders of the thyroid gland (ICD-10: E0)<br></span>
<span style="margin-left:2em;"><a href="E4_CONGEIOD.html">[3] E4_CONGEIOD</a>: Congenital iodine-deficiency syndrome/hypothyroidism (ICD-10: E00|E03[0-1])<br></span>
<span style="margin-left:2em;"><a href="E4_IODGOITRE.html">[3] E4_IODGOITRE</a>: Iodine-deficiency-related goitre (ICD-10: E01)<br></span>
<span style="margin-left:2em;"><a href="E4_IODTHYR.html">[3] E4_IODTHYR</a>: Iodine-deficiency-related thyroid disorders and allied conditions (ICD-10: E018)<br></span>
<span style="margin-left:2em;"><a href="E4_IODHYPSUB.html">[3] E4_IODHYPSUB</a>: Subclinical iodine-deficiency hypothyroidism (ICD-10: E02)<br></span>
<span style="margin-left:2em;"><a href="E4_HYTHYSUBS.html">[3] E4_HYTHYSUBS</a>: Hypothyroidism due to medicaments and other exogenous substances (ICD-10: E032)<br></span>
<span style="margin-left:2em;"><a href="E4_HYTHYPOSTINF.html">[3] E4_HYTHYPOSTINF</a>: Postinfectious hypothyroidism (ICD-10: E033)<br></span>
<span style="margin-left:2em;"><a href="E4_ATROTHY.html">[3] E4_ATROTHY</a>: Atrophy of thyroid (acquired) (ICD-10: E034)<br></span>
<span style="margin-left:2em;"><a href="E4_MYXOCO.html">[3] E4_MYXOCO</a>: Myxoedema coma (ICD-10: E035)<br></span>
<span style="margin-left:2em;"><a href="E4_HYTHYNAS.html">[3] E4_HYTHYNAS</a>: Hypothyroidism,other/unspecified (ICD-10: E03[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_GOITREDIFF.html">[3] E4_GOITREDIFF</a>: Nontoxic diffuse goitre (ICD-10: E040)<br></span>
<span style="margin-left:2em;"><a href="E4_GOITRENOD.html">[3] E4_GOITRENOD</a>: Nontoxic single thyroid nodule (ICD-10: E041)<br></span>
<span style="margin-left:2em;"><a href="E4_GOITREMULTINOD.html">[3] E4_GOITREMULTINOD</a>: Nontoxic multinodular goitre (ICD-10: E042)<br></span>
<span style="margin-left:2em;"><a href="E4_GOITRENAS.html">[3] E4_GOITRENAS</a>: Other and/or unspecified nontoxic goitre (ICD-10: E04[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_THYTOXGOITDIF.html">[3] E4_THYTOXGOITDIF</a>: Thyrotoxicosis with diffuse goitr (ICD-10: E050)<br></span>
<span style="margin-left:2em;"><a href="E4_THYTOXECT.html">[3] E4_THYTOXECT</a>: Thyrotoxicosis from ectopic thyroid tissue (ICD-10: E053)<br></span>
<span style="margin-left:2em;"><a href="E4_THYCRISIS.html">[3] E4_THYCRISIS</a>: Thyroid crisis or storm (ICD-10: E055)<br></span>
<span style="margin-left:2em;"><a href="E4_THYTOXNAS.html">[3] E4_THYTOXNAS</a>: Thyrotoxicosis, other and/or unspecified (ICD-10: E05[4-9])<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDITACU.html">[3] E4_THYROIDITACU</a>: Acute thyroiditis (ICD-10: E060)<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDITSUBAC.html">[3] E4_THYROIDITSUBAC</a>: Subacute thyroiditis (ICD-10: E061)<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDITCHRON.html">[3] E4_THYROIDITCHRON</a>: Chronic thyroiditis (ICD-10: E06[28])<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDITAUTOIM.html">[3] E4_THYROIDITAUTOIM</a>: Autoimmune thyroiditis (ICD-10: E063)<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDITDRUG.html">[3] E4_THYROIDITDRUG</a>: Drug-induced thyroiditis (ICD-10: E064)<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDITNAS.html">[3] E4_THYROIDITNAS</a>: Thyroiditis, unspecified (ICD-10: E069)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERSECCAL.html">[3] E4_HYPERSECCAL</a>: Hypersecretion of calcitonin (ICD-10: E070)<br></span>
<span style="margin-left:2em;"><a href="E4_GOITREDYS.html">[3] E4_GOITREDYS</a>: Dyshormogenetic goitre (ICD-10: E071)<br></span>
<span style="margin-left:2em;"><a href="E4_THYROIDNASOTH.html">[3] E4_THYROIDNASOTH</a>: Disorder of thyroid, unspecified (ICD-10: E07[8-9])<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_DIABETES.html">[2] E4_DIABETES</a>: Diabetes mellitus (ICD-10: E1[0-4])<br></span>
<span style="margin-left:0em;"><a href="E4_DM1.html">[C] E4_DM1</a>: Type 1 diabetes (ICD-10: E10)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1COMA.html">[3] E4_DM1COMA</a>: Type 1 diabetes with coma (ICD-10: E100)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1KETO.html">[3] E4_DM1KETO</a>: Type 1 diabetes with ketoacidosis (ICD-10: E101)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1REN.html">[3] E4_DM1REN</a>: Type 1 diabetes with renal complications (ICD-10: E102)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1OPTH.html">[3] E4_DM1OPTH</a>: Type 1 diabetes with ophthalmic complications (ICD-10: E103)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1NEU.html">[3] E4_DM1NEU</a>: Type 1 diabetes with neurological complications (ICD-10: E104)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1PERIPH.html">[3] E4_DM1PERIPH</a>: Type 1 diabetes with peripheral circulatory complications (ICD-10: E105)<br></span>
<span style="margin-left:2em;"><a href="E4_DM1NASCOMP.html">[3] E4_DM1NASCOMP</a>: Type 1 diabetes with other specified/multiple/unspecified complications (ICD-10: E10[6-8])<br></span>
<span style="margin-left:2em;"><a href="E4_DM1NOCOMP.html">[3] E4_DM1NOCOMP</a>: Type 1 diabetes without complications (ICD-10: E109)<br></span>
<span style="margin-left:0em;"><a href="E4_DM2.html">[C] E4_DM2</a>: Type 2 diabetes (ICD-10: E11)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2COMA.html">[3] E4_DM2COMA</a>: Type 2 diabetes with coma (ICD-10: E110)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2KETO.html">[3] E4_DM2KETO</a>: Type 2 diabetes with ketoacidosis (ICD-10: E111)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2REN.html">[3] E4_DM2REN</a>: Type 2 diabetes with renal complications (ICD-10: E112)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2OPTH.html">[3] E4_DM2OPTH</a>: Type 2 diabetes with ophthalmic complications (ICD-10: E113)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2NEU.html">[3] E4_DM2NEU</a>: Type 2 diabetes with neurological complications (ICD-10: E114)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2PERIPH.html">[3] E4_DM2PERIPH</a>: Type 2 diabetes with peripheral circulatory complications (ICD-10: E115)<br></span>
<span style="margin-left:2em;"><a href="E4_DM2NASCOMP.html">[3] E4_DM2NASCOMP</a>: Type 2 diabetes with other specified/multiple/unspecified complications (ICD-10: E11[6-8])<br></span>
<span style="margin-left:2em;"><a href="E4_DM2NOCOMP.html">[3] E4_DM2NOCOMP</a>: Type 2 diabetes without complications (ICD-10: E119)<br></span>
<span style="margin-left:0em;"><a href="E4_DMNAS.html">[C] E4_DMNAS</a>: Unspecified diabetes (ICD-10: E1[2-4])<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASCOMA.html">[3] E4_DMNASCOMA</a>: Unspecified diabetes with coma (ICD-10: E1[2-4]0)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASKETO.html">[3] E4_DMNASKETO</a>: Unspecified diabetes with ketoacidosis (ICD-10: E1[2-4]1)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASREN.html">[3] E4_DMNASREN</a>: Unspecified diabetes with renal complications (ICD-10: E1[2-4]2)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASOPTH.html">[3] E4_DMNASOPTH</a>: Unspecified diabetes with ophthalmic complications (ICD-10: E1[2-4]3)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASNEU.html">[3] E4_DMNASNEU</a>: Unspecified diabetes with neurological complications (ICD-10: E1[2-4]4)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASPERIPH.html">[3] E4_DMNASPERIPH</a>: Unspecified diabetes with peripheral circulatory complications (ICD-10: E1[2-4]5)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASNASCOMP.html">[3] E4_DMNASNASCOMP</a>: Unspecified diabetes with multiple/unspecified complications (ICD-10: E1[2-4][7-8])<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASOTHCOMP.html">[3] E4_DMNASOTHCOMP</a>: Unspecified diabetes with other specified complications (ICD-10: E1[2-4]6)<br></span>
<span style="margin-left:2em;"><a href="E4_DMNASNOCOMP.html">[3] E4_DMNASNOCOMP</a>: Unspecified diabetes without complications (ICD-10: E1[2-4]9)<br></span>
<span style="margin-left:0em;"><a href="E4_DMICD8.html">[C] E4_DMICD8</a>: Diabetes, unspecified because of ICD-8 (ICD-8: 250)<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8COMA.html">[3] E4_DMICD8COMA</a>: Diabetes, unspecified because of ICD-8, with coma (ICD-8: 25000)<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8REN.html">[3] E4_DMICD8REN</a>: Diabetes, unspecified because of ICD-8, with renal complications (ICD-8: 25004)<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8OPTH.html">[3] E4_DMICD8OPTH</a>: Diabetes, unspecified because of ICD-8, with ophthalmic complications (ICD-8: 2500[1-3])<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8NEU.html">[3] E4_DMICD8NEU</a>: Diabetes, unspecified because of ICD-8, with neurological complications (ICD-8: 25005)<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8PERIPH.html">[3] E4_DMICD8PERIPH</a>: Diabetes, unspecified because of ICD-8, with peripheral circulatory complications (ICD-8: 25006)<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8OTHCOMP.html">[3] E4_DMICD8OTHCOMP</a>: Diabetes, unspecified because of ICD-8, with other specified complications (ICD-8: 250)<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8NASCOMP.html">[3] E4_DMICD8NASCOMP</a>: Diabetes, unspecified because of ICD-8, with multiple/unspecified complications (ICD-8: 2500[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_DMICD8NOCOMP.html">[3] E4_DMICD8NOCOMP</a>: Diabetes, unspecified because of ICD-8, without complications (ICD-8: 25000)<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_GLUCOPANCREAS.html">[2] E4_GLUCOPANCREAS</a>: Other disorders of glucose regulation and pancreatic internal secretion (ICD-10: E1[5-6])<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOCOMA.html">[3] E4_HYPOCOMA</a>: Nondiabetic hypoglycaemic coma (ICD-10: E15)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPODRUG.html">[3] E4_HYPODRUG</a>: Drug-induced hypoglycaemia without coma (ICD-10: E160)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOGLYC.html">[3] E4_HYPOGLYC</a>: Hypoglycaemia, other or unspecified (ICD-10: E16[1-2])<br></span>
<span style="margin-left:2em;"><a href="E4_GLUCAGONPLUS.html">[3] E4_GLUCAGONPLUS</a>: Increased secretion of glucagon (ICD-10: E163)<br></span>
<span style="margin-left:2em;"><a href="E4_ABNGASTRIN.html">[3] E4_ABNGASTRIN</a>: Abnormal secretion of gastrin (ICD-10: E164)<br></span>
<span style="margin-left:2em;"><a href="E4_PANCSECNAS.html">[3] E4_PANCSECNAS</a>: Disorder of pancreatic internal secretion, other and/or unspecified (ICD-10: E16[8-9])<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_ENDOGLAND.html">[2] E4_ENDOGLAND</a>: Disorders of other endocrine glands (ICD-10: E[2-3])<br></span>
<span style="margin-left:0em;"><a href="E4_PARATHYRO.html">[C] E4_PARATHYRO</a>: Disorders of parathyroid gland (ICD-10: E2[0-1])<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOPARA.html">[3] E4_HYPOPARA</a>: Hypoparathyroidism (ICD-10: E20)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERPARA.html">[3] E4_HYPERPARA</a>: Hyperparathyroidism (ICD-10: E21[0-3])<br></span>
<span style="margin-left:2em;"><a href="E4_PARANAS.html">[3] E4_PARANAS</a>: Disorders of parathyroid gland, other and/or unspecified (ICD-10: E21[4-5])<br></span>
<span style="margin-left:0em;"><a href="E4_HYPERPIT.html">[C] E4_HYPERPIT</a>: Hyperfunction of pituitary gland (ICD-10: E22)<br></span>
<span style="margin-left:2em;"><a href="E4_ACROMEG.html">[3] E4_ACROMEG</a>: Acromegaly and pituitary gigantism (ICD-10: E220)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERPRO.html">[3] E4_HYPERPRO</a>: Hyperprolactinaemia (ICD-10: E221)<br></span>
<span style="margin-left:2em;"><a href="E4_ANTIDIU.html">[3] E4_ANTIDIU</a>: Syndrome of inappropriate secretion of antidiuretic hormone (ICD-10: E222)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERPITNAS.html">[3] E4_HYPERPITNAS</a>: Hyperfunction of pituitary gland, other and/or unspecified (ICD-10: E223)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOPIT.html">[3] E4_HYPOPIT</a>: Hypopituitarism (ICD-10: E230)<br></span>
<span style="margin-left:2em;"><a href="E4_DIABINSIPIDUS.html">[3] E4_DIABINSIPIDUS</a>: Diabetes insipidus (ICD-10: E232)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOTHALDYSF.html">[3] E4_HYPOTHALDYSF</a>: Hypothalamic dysfunction, including iatrogenic, not elsewhere classified (ICD-10: E23[13])<br></span>
<span style="margin-left:2em;"><a href="E4_PITUDISNAS.html">[3] E4_PITUDISNAS</a>: Disorders of pituitary gland, other and/or unspecified (ICD-10: E23[6-7])<br></span>
<span style="margin-left:2em;"><a href="E4_CUSHING.html">[3] E4_CUSHING</a>: Cushing syndrome (ICD-10: E24)<br></span>
<span style="margin-left:2em;"><a href="E4_ADRENOGEN.html">[3] E4_ADRENOGEN</a>: Adrenoogenital disorders (ICD-10: E25)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERALDO.html">[3] E4_HYPERALDO</a>: Hyperaldosteronism (ICD-10: E26)<br></span>
<span style="margin-left:0em;"><a href="E4_ADRENAL.html">[C] E4_ADRENAL</a>: Other disorders of adrenal gland (ICD-10: E27)<br></span>
<span style="margin-left:2em;"><a href="E4_ADREACT.html">[3] E4_ADREACT</a>: Other adrenocortical overactivity (ICD-10: E270)<br></span>
<span style="margin-left:2em;"><a href="E4_ADDISON.html">[3] E4_ADDISON</a>: Adrenocortical insufficiency (ICD-10: E27[1-4])<br></span>
<span style="margin-left:2em;"><a href="E4_ADREMEDHYPER.html">[3] E4_ADREMEDHYPER</a>: Adrenomedullary hyperfunction (ICD-10: E275)<br></span>
<span style="margin-left:2em;"><a href="E4_ADRENAS.html">[3] E4_ADRENAS</a>: Disorders of adrenal gland, other and/or unspecified (ICD-10: E27[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_OVARDYS.html">[C] E4_OVARDYS</a>: Ovarian dysfunction (ICD-10: E28)<br></span>
<span style="margin-left:2em;"><a href="E4_ODESTRO.html">[3] E4_ODESTRO</a>: Ovarian dysfunction: estrogen excess (ICD-10: E280)<br></span>
<span style="margin-left:2em;"><a href="E4_ODANDRO.html">[3] E4_ODANDRO</a>: Ovarian dysfunction: androgen excess (ICD-10: E281)<br></span>
<span style="margin-left:2em;"><a href="E4_POCS.html">[3] E4_POCS</a>: Polycystic ovarian syndrome (ICD-10: E282)<br></span>
<span style="margin-left:2em;"><a href="E4_OVARFAIL.html">[3] E4_OVARFAIL</a>: Primary ovarian failure (ICD-10: E283)<br></span>
<span style="margin-left:2em;"><a href="E4_OVARDYSNAS.html">[3] E4_OVARDYSNAS</a>: Ovarian dysfunction, other/unspecified (ICD-10: E28[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_TESTIDYS.html">[C] E4_TESTIDYS</a>: Testicular dysfunction (ICD-10: E29)<br></span>
<span style="margin-left:2em;"><a href="E4_TESTICHYPER.html">[3] E4_TESTICHYPER</a>: Testicular hyperfunction (ICD-10: E290)<br></span>
<span style="margin-left:2em;"><a href="E4_TESTICHYPO.html">[3] E4_TESTICHYPO</a>: Testicular hypofunction (ICD-10: E291)<br></span>
<span style="margin-left:2em;"><a href="E4_TESTICDYSNAS.html">[3] E4_TESTICDYSNAS</a>: Testicular dysfunction, other/unspecified (ICD-10: E29[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_DISPUB.html">[C] E4_DISPUB</a>: Disorders of puberty (ICD-10: E30)<br></span>
<span style="margin-left:2em;"><a href="E4_DELPUB.html">[3] E4_DELPUB</a>: Delayed puberty (ICD-10: E300)<br></span>
<span style="margin-left:2em;"><a href="E4_PREPUB.html">[3] E4_PREPUB</a>: Precocious puberty (ICD-10: E301)<br></span>
<span style="margin-left:2em;"><a href="E4_PUBDISNAS.html">[3] E4_PUBDISNAS</a>: Disorders of puberty, other/unspecified (ICD-10: E30[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_DYSPOLYGL.html">[C] E4_DYSPOLYGL</a>: Polyglandular dysfunction (ICD-10: E31)<br></span>
<span style="margin-left:2em;"><a href="E4_AUTOPOLYFAI.html">[3] E4_AUTOPOLYFAI</a>: Autoimmune polyglandular failure (ICD-10: E310)<br></span>
<span style="margin-left:2em;"><a href="E4_POLYHYPER.html">[3] E4_POLYHYPER</a>: Polyglandular hyperfunction (ICD-10: E311)<br></span>
<span style="margin-left:2em;"><a href="E4_POLYDYSNAS.html">[3] E4_POLYDYSNAS</a>: Polyglandular dysfunction, other/unspecified (ICD-10: E31[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_THYMUSDIS.html">[C] E4_THYMUSDIS</a>: Diseases of thymus (ICD-10: E32)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERTHY.html">[3] E4_HYPERTHY</a>: Persistent hyperplasia of thymus (ICD-10: E320)<br></span>
<span style="margin-left:2em;"><a href="E4_ABSCTHY.html">[3] E4_ABSCTHY</a>: Abscess of thymus (ICD-10: E321)<br></span>
<span style="margin-left:2em;"><a href="E4_THYMUSDISNAS.html">[3] E4_THYMUSDISNAS</a>: Disease of thymus, other/unspecified (ICD-10: E32[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_ENDODIS.html">[C] E4_ENDODIS</a>: Other endocrine disorders (ICD-10: E3[4-5])<br></span>
<span style="margin-left:2em;"><a href="E4_CARCISDR.html">[3] E4_CARCISDR</a>: Carcinoid syndrome (ICD-10: E340)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERSEC.html">[3] E4_HYPERSEC</a>: Other hypersecretion of intestinal hormones (ICD-10: E341)<br></span>
<span style="margin-left:2em;"><a href="E4_ECTHOR.html">[3] E4_ECTHOR</a>: Ectopic hormone secretion, not elsewhere classified (ICD-10: E342)<br></span>
<span style="margin-left:2em;"><a href="E4_SHORT.html">[3] E4_SHORT</a>: Short stature, not elsewhere classified (ICD-10: E343)<br></span>
<span style="margin-left:2em;"><a href="E4_TALL.html">[3] E4_TALL</a>: Constitutional tall stature (ICD-10: E344)<br></span>
<span style="margin-left:2em;"><a href="E4_ANDRORESIST.html">[3] E4_ANDRORESIST</a>: Androgen resistance syndrome (ICD-10: E345)<br></span>
<span style="margin-left:2em;"><a href="E4_ENDODISNAS.html">[3] E4_ENDODISNAS</a>: Endocrine disorders, other/unspecified (ICD-10: E34[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_ENDINOTH.html">[3] E4_ENDINOTH</a>: Disorders of endocrine glands in diseases classified elsewhere (ICD-10: E35)<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_MALNUTRITION.html">[2] E4_MALNUTRITION</a>: Malnutrition (ICD-10: E4)<br></span>
<span style="margin-left:2em;"><a href="E4_KWASHIORKOR.html">[3] E4_KWASHIORKOR</a>: Kwashiorkor (ICD-10: E40)<br></span>
<span style="margin-left:2em;"><a href="E4_MARASMUS.html">[3] E4_MARASMUS</a>: Nutritional marasmus (ICD-10: E41)<br></span>
<span style="margin-left:2em;"><a href="E4_MARAKWASH.html">[3] E4_MARAKWASH</a>: Marasmic kwashiorkor (ICD-10: E42)<br></span>
<span style="margin-left:2em;"><a href="E4_PROTMALSEVERNAS.html">[3] E4_PROTMALSEVERNAS</a>: Unspecified severe protein-energy malnutrition (ICD-10: E43)<br></span>
<span style="margin-left:2em;"><a href="E4_PROTMALMODMILD.html">[3] E4_PROTMALMODMILD</a>: Protein-energy malnutrition of moderate and mild degree (ICD-10: E44)<br></span>
<span style="margin-left:2em;"><a href="E4_PROTMALRETARD.html">[3] E4_PROTMALRETARD</a>: Retarded development following protein-energy malnutrition (ICD-10: E45)<br></span>
<span style="margin-left:2em;"><a href="E4_PROTMALNAS.html">[3] E4_PROTMALNAS</a>: Unspecified protein-energy malnutrition (ICD-10: E46)<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_NUTRIDEF.html">[2] E4_NUTRIDEF</a>: Other nutritional deficiencies (ICD-10: E[5-6])<br></span>
<span style="margin-left:2em;"><a href="E4_VIT_DEF.html">[3] E4_VIT_DEF</a>: Vitamin deficiency (ICD-10: E5[0-6])<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_A_DEF.html">[4] E4_VIT_A_DEF</a>: Vitamin A deficiency (ICD-10: E50)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_THIA_DEF.html">[4] E4_THIA_DEF</a>: Thiamine deficiency (ICD-10: E51)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_NIAC_DEF.html">[4] E4_NIAC_DEF</a>: Nacin deficiency [pellagra] (ICD-10: E52)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_B_DEF.html">[4] E4_VIT_B_DEF</a>: Deficiency of other B group vitamins (ICD-10: E53)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_C_DEF.html">[4] E4_VIT_C_DEF</a>: Ascorbic acid deficiency (ICD-10: E54)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_D_DEF.html">[4] E4_VIT_D_DEF</a>: Vitamin D deficiency (ICD-10: E55)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_E_DEF.html">[4] E4_VIT_E_DEF</a>: Deficiency of vitamin E (ICD-10: E560)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_K_DEF.html">[4] E4_VIT_K_DEF</a>: Deficiency of vitamin K (ICD-10: E561)<br></span>
<span style="margin-left:3em; font-size:85%;"><a href="E4_VIT_NAS_DEF.html">[4] E4_VIT_NAS_DEF</a>: Deficiency of other/unspecified vitamins (ICD-10: E56[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_CA_DEF.html">[3] E4_CA_DEF</a>: Dietary calcium deficiency (ICD-10: E58)<br></span>
<span style="margin-left:2em;"><a href="E4_SELE_DEF.html">[3] E4_SELE_DEF</a>: Dietary selenium deficiency (ICD-10: E59)<br></span>
<span style="margin-left:2em;"><a href="E4_ZINC_DEF.html">[3] E4_ZINC_DEF</a>: Dietary zinc deficiency (ICD-10: E60)<br></span>
<span style="margin-left:2em;"><a href="E4_COPP_DEF.html">[3] E4_COPP_DEF</a>: Copper deficiency (ICD-10: E610)<br></span>
<span style="margin-left:2em;"><a href="E4_FE_DEF.html">[3] E4_FE_DEF</a>: Iron deficiency (ICD-10: E611)<br></span>
<span style="margin-left:2em;"><a href="E4_MG_DEF.html">[3] E4_MG_DEF</a>: Magnesium deficiency (ICD-10: E612)<br></span>
<span style="margin-left:2em;"><a href="E4_MANG_DEF.html">[3] E4_MANG_DEF</a>: Manganese deficiency (ICD-10: E613)<br></span>
<span style="margin-left:2em;"><a href="E4_CHRO_DEF.html">[3] E4_CHRO_DEF</a>: Chromium deficiency (ICD-10: E614)<br></span>
<span style="margin-left:2em;"><a href="E4_MOLYB_DEF.html">[3] E4_MOLYB_DEF</a>: Molybdenum deficiency (ICD-10: E615)<br></span>
<span style="margin-left:2em;"><a href="E4_VANA_DEF.html">[3] E4_VANA_DEF</a>: Vanadium deficiency (ICD-10: E616)<br></span>
<span style="margin-left:2em;"><a href="E4_MULTI_DEF.html">[3] E4_MULTI_DEF</a>: Deficiency of multiple nutrient elements (ICD-10: E617)<br></span>
<span style="margin-left:2em;"><a href="E4_NUTRIEL_NAS_DEF.html">[3] E4_NUTRIEL_NAS_DEF</a>: Deficiency of other/unspecified nutrient elements (ICD-10: E61[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_FAT_DEF.html">[3] E4_FAT_DEF</a>: Essential fatty acid [EFA] deficiency (ICD-10: E630)<br></span>
<span style="margin-left:2em;"><a href="E4_IMBAL_FOOD.html">[3] E4_IMBAL_FOOD</a>: Imbalance of constituents of food intake (ICD-10: E631)<br></span>
<span style="margin-left:2em;"><a href="E4_NUTRI_DEF_NAS.html">[3] E4_NUTRI_DEF_NAS</a>: Other specified/unspecified nutritional deficiencies (ICD-10: E63[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_SEQUMAL.html">[3] E4_SEQUMAL</a>: Sequelae of malnutrition and other nutritional deficiencies (ICD-10: E64)<br></span>
<span style="margin-left:0em;"><a href="E4_OBESITY.html">[C] E4_OBESITY</a>: Obesity (ICD-10: E66)<br></span>
<span style="margin-left:2em;"><a href="E4_OBESITYCAL.html">[3] E4_OBESITYCAL</a>: Obesity due to excess calories (ICD-10: E660)<br></span>
<span style="margin-left:2em;"><a href="E4_OBESITYDRUG.html">[3] E4_OBESITYDRUG</a>: Drug-induced obesity (ICD-10: E661)<br></span>
<span style="margin-left:2em;"><a href="E4_OBESITYXTRMALV.html">[3] E4_OBESITYXTRMALV</a>: Extreme obesity with alveolar hypoventilation (ICD-10: E662)<br></span>
<span style="margin-left:2em;"><a href="E4_OBESITYNAS.html">[3] E4_OBESITYNAS</a>: Obesity, other/unspecified (ICD-10: E66[8-9])<br></span>
<span style="margin-left:1em; font-size:130%;"><a href="E4_METABOLIA.html">[2] E4_METABOLIA</a>: Metabolic disorders (ICD-10: E[7-9])<br></span>
<span style="margin-left:0em;"><a href="E4_AROMAMINO.html">[C] E4_AROMAMINO</a>: Disorders of aromatic amino-acid metabolism (ICD-10: E70)<br></span>
<span style="margin-left:2em;"><a href="E4_PHENYLKETOUR.html">[3] E4_PHENYLKETOUR</a>: Classical phenylketonuria (ICD-10: E700)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERPHENYLNAS.html">[3] E4_HYPERPHENYLNAS</a>: Other hyperphenylalaninaemias (ICD-10: E701)<br></span>
<span style="margin-left:2em;"><a href="E4_TYROSINE.html">[3] E4_TYROSINE</a>: Disorders of tyrosine metabolism (ICD-10: E702)<br></span>
<span style="margin-left:2em;"><a href="E4_ALBINISM.html">[3] E4_ALBINISM</a>: Albinism (ICD-10: E703)<br></span>
<span style="margin-left:2em;"><a href="E4_AROMAMINONAS.html">[3] E4_AROMAMINONAS</a>: Dsorders of aromatic amino-acid metabolism, other/unspecified (ICD-10: E70[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_BRANCHAMINOFATAC.html">[C] E4_BRANCHAMINOFATAC</a>: Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism (ICD-10: E71)<br></span>
<span style="margin-left:2em;"><a href="E4_MAPLESYRUP.html">[3] E4_MAPLESYRUP</a>: Maple-syrup-urine disease (ICD-10: E710)<br></span>
<span style="margin-left:2em;"><a href="E4_BRANCHAMINONAS.html">[3] E4_BRANCHAMINONAS</a>: Disorders of branched-chain amino-acid metabolism, other/unspecified (ICD-10: E71[1-2])<br></span>
<span style="margin-left:2em;"><a href="E4_FATTYACID.html">[3] E4_FATTYACID</a>: Disorders of fatty-acid metabolism (ICD-10: E713)<br></span>
<span style="margin-left:0em;"><a href="E4_AMINO.html">[C] E4_AMINO</a>: Other disorders of amino-acid metabolism (ICD-10: E72)<br></span>
<span style="margin-left:2em;"><a href="E4_AMINOTRANSPORT.html">[3] E4_AMINOTRANSPORT</a>: Disorders of amino-acid transport (ICD-10: E720)<br></span>
<span style="margin-left:2em;"><a href="E4_SULFURMET.html">[3] E4_SULFURMET</a>: Disorders of sulfur-bearing amino-acid metabolism (ICD-10: E721)<br></span>
<span style="margin-left:2em;"><a href="E4_UREACYCLE.html">[3] E4_UREACYCLE</a>: Disorders of urea cycle metabolism (ICD-10: E722)<br></span>
<span style="margin-left:2em;"><a href="E4_LYSINEHYDRO.html">[3] E4_LYSINEHYDRO</a>: Disorders of lysine and hydroxylysine metabolism (ICD-10: E723)<br></span>
<span style="margin-left:2em;"><a href="E4_ORNITHINE.html">[3] E4_ORNITHINE</a>: Disorders of ornithine metabolism (ICD-10: E724)<br></span>
<span style="margin-left:2em;"><a href="E4_GLYCINE.html">[3] E4_GLYCINE</a>: Disorders of glycine metabolism (ICD-10: E725)<br></span>
<span style="margin-left:2em;"><a href="E4_AMINONAS.html">[3] E4_AMINONAS</a>: Disorder of amino-acid metabolism, other/unspecified (ICD-10: E72[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_LACTOSEINT.html">[C] E4_LACTOSEINT</a>: Lactose intolerance (ICD-10: E73)<br></span>
<span style="margin-left:2em;"><a href="E4_LACTOCON.html">[3] E4_LACTOCON</a>: Congenital lactase deficiency (ICD-10: E730)<br></span>
<span style="margin-left:2em;"><a href="E4_LACTOSEC.html">[3] E4_LACTOSEC</a>: Secondary lactase deficiency (ICD-10: E731)<br></span>
<span style="margin-left:2em;"><a href="E4_LACTONAS.html">[3] E4_LACTONAS</a>: Lactose intolerance, other/unspecified (ICD-10: E73[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_CARBO.html">[C] E4_CARBO</a>: Other disorders of carbohydrate metabolism (ICD-10: E74[0-48-9])<br></span>
<span style="margin-left:2em;"><a href="E4_GLYCOSTOR.html">[3] E4_GLYCOSTOR</a>: Glycogen storage disease (ICD-10: E740)<br></span>
<span style="margin-left:2em;"><a href="E4_FRUCT.html">[3] E4_FRUCT</a>: Disorders of fructose metabolism (ICD-10: E741)<br></span>
<span style="margin-left:2em;"><a href="E4_GALACT.html">[3] E4_GALACT</a>: Disorders of galactose metabolism (ICD-10: E742)<br></span>
<span style="margin-left:2em;"><a href="E4_CARBABS.html">[3] E4_CARBABS</a>: Other disorders of intestinal carbohydrate absorption (ICD-10: E743)<br></span>
<span style="margin-left:2em;"><a href="E4_PYRUGLUNEO.html">[3] E4_PYRUGLUNEO</a>: Disorders of pyruvate metabolism and gluconeogenesi (ICD-10: E744)<br></span>
<span style="margin-left:2em;"><a href="E4_CARBONAS.html">[3] E4_CARBONAS</a>: Disorder of carbohydrate metabolism, other/unspecified (ICD-10: E74[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_SPHINGOLIP.html">[C] E4_SPHINGOLIP</a>: Disorders of sphingolipid metabolism and other lipid storage disorders (ICD-10: E75)<br></span>
<span style="margin-left:2em;"><a href="E4_GM2GANGLIO.html">[3] E4_GM2GANGLIO</a>: GM2 gangliosidosis (ICD-10: E750)<br></span>
<span style="margin-left:2em;"><a href="E4_GANGLIOSID.html">[3] E4_GANGLIOSID</a>: Other gangliosidosis (ICD-10: E751)<br></span>
<span style="margin-left:2em;"><a href="E4_SPHIGLOLIPNAS.html">[3] E4_SPHIGLOLIPNAS</a>: Sphingolipidosis, other/unspecified (ICD-10: E75[2-3])<br></span>
<span style="margin-left:2em;"><a href="E4_NEUROCER.html">[3] E4_NEUROCER</a>: Neuronal ceroid lipofuscinosis (ICD-10: E754)<br></span>
<span style="margin-left:2em;"><a href="E4_LIPIDSTORNAS.html">[3] E4_LIPIDSTORNAS</a>: Lipid storage disorder, other/unspecified (ICD-10: E75[5-6])<br></span>
<span style="margin-left:0em;"><a href="E4_GLYCOSAMINOGLYC.html">[C] E4_GLYCOSAMINOGLYC</a>: Disorders of glycosaminoglycan metabolism (ICD-10: E76)<br></span>
<span style="margin-left:2em;"><a href="E4_MUCOPOLY1.html">[3] E4_MUCOPOLY1</a>: Mucopolysaccharidosis, type I (ICD-10: E760)<br></span>
<span style="margin-left:2em;"><a href="E4_MUCOPOLY2.html">[3] E4_MUCOPOLY2</a>: Mucopolysaccharidosis, type II (ICD-10: E761)<br></span>
<span style="margin-left:2em;"><a href="E4_MUCOPOLYNAS.html">[3] E4_MUCOPOLYNAS</a>: Mucopolysaccharidosis, other/unspecified (ICD-10: E76[2-3])<br></span>
<span style="margin-left:2em;"><a href="E4_GLUCOSAMINOGLYCNAS.html">[3] E4_GLUCOSAMINOGLYCNAS</a>: Disorders of glycosaminoglycan metabolism, other/unspecified (ICD-10: E76[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_GLYCOPROT.html">[C] E4_GLYCOPROT</a>: Disorders of glycoprotein metabolism (ICD-10: E77)<br></span>
<span style="margin-left:2em;"><a href="E4_LYSOPOSTTRANS.html">[3] E4_LYSOPOSTTRANS</a>: Defects in post-translational modification of lysosomal enzymes (ICD-10: E770)<br></span>
<span style="margin-left:2em;"><a href="E4_GLYCOPROTDEGR.html">[3] E4_GLYCOPROTDEGR</a>: Defects in glycoprotein degradation (ICD-10: E771)<br></span>
<span style="margin-left:2em;"><a href="E4_GLYCOPROTNAS.html">[3] E4_GLYCOPROTNAS</a>: Disorders of glycoprotein metabolism, other/unspecified (ICD-10: E77[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_LIPOPROT.html">[C] E4_LIPOPROT</a>: Disorders of lipoprotein metabolism and other lipidaemias (ICD-10: E78)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERCHOL.html">[3] E4_HYPERCHOL</a>: Pure hypercholesterolaemia (ICD-10: E780)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERGLYCER.html">[3] E4_HYPERGLYCER</a>: Pure hyperglyceridaemia (ICD-10: E781)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERLIPMIX.html">[3] E4_HYPERLIPMIX</a>: Mixed hyperlipidaemia (ICD-10: E782)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERCHYLO.html">[3] E4_HYPERCHYLO</a>: Hyperchylomicronaemia (ICD-10: E783)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERLIPNAS.html">[3] E4_HYPERLIPNAS</a>: Hyperlipidaemia, other/unspecified (ICD-10: E78[4-5])<br></span>
<span style="margin-left:2em;"><a href="E4_LIPODEF.html">[3] E4_LIPODEF</a>: Lipoprotein deficiency (ICD-10: E786)<br></span>
<span style="margin-left:2em;"><a href="E4_LIPOPROTNAS.html">[3] E4_LIPOPROTNAS</a>: Disorder of lipoprotein metabolism, unspecified (ICD-10: E78[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_PURINEPYRI.html">[C] E4_PURINEPYRI</a>: Disorders of purine and pyrimidine metabolism (ICD-10: E79)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERURI.html">[3] E4_HYPERURI</a>: Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease (ICD-10: E790)<br></span>
<span style="margin-left:2em;"><a href="E4_LESCHNYMAN.html">[3] E4_LESCHNYMAN</a>: Lesch-Nyhan syndrome (ICD-10: E791)<br></span>
<span style="margin-left:2em;"><a href="E4_PURINEPYRINAS.html">[3] E4_PURINEPYRINAS</a>: Disorders of purine and pyrimidine metabolism, other/unspecified (ICD-10: E79[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_PORBILIR.html">[C] E4_PORBILIR</a>: Disorders of porphyrin and bilirubin metabolism (ICD-10: E80)<br></span>
<span style="margin-left:2em;"><a href="E4_HERERYPOR.html">[3] E4_HERERYPOR</a>: Hereditary erythropoietic porphyria (ICD-10: E800)<br></span>
<span style="margin-left:2em;"><a href="E4_PORCUTTAR.html">[3] E4_PORCUTTAR</a>: Porphyria cutanea tarda (ICD-10: E801)<br></span>
<span style="margin-left:2em;"><a href="E4_PORPHYNAS.html">[3] E4_PORPHYNAS</a>: Other porphyria (ICD-10: E802)<br></span>
<span style="margin-left:2em;"><a href="E4_CATAPEROXDEF.html">[3] E4_CATAPEROXDEF</a>: Defects of catalase and peroxidase (ICD-10: E803)<br></span>
<span style="margin-left:2em;"><a href="E4_GILBERT.html">[3] E4_GILBERT</a>: Gilbert syndrome (ICD-10: E804)<br></span>
<span style="margin-left:2em;"><a href="E4_CRIGLERNAJJAR.html">[3] E4_CRIGLERNAJJAR</a>: Crigler-Najjar syndrome (ICD-10: E805)<br></span>
<span style="margin-left:2em;"><a href="E4_PORBILIRNAS.html">[3] E4_PORBILIRNAS</a>: Disorder of bilirubin metabolism, other/unspecified (ICD-10: E80[6-7])<br></span>
<span style="margin-left:0em;"><a href="E4_MINERAL_MET.html">[C] E4_MINERAL_MET</a>: Disorders of mineral metabolism (ICD-10: E83)<br></span>
<span style="margin-left:2em;"><a href="E4_COPPER_MET.html">[3] E4_COPPER_MET</a>: Disorders of copper metabolism (ICD-10: E830)<br></span>
<span style="margin-left:2em;"><a href="E4_IRON_MET.html">[3] E4_IRON_MET</a>: Disorders of iron metabolism (ICD-10: E831)<br></span>
<span style="margin-left:2em;"><a href="E4_ZINC_MET.html">[3] E4_ZINC_MET</a>: Disorders of zinc metabolism (ICD-10: E832)<br></span>
<span style="margin-left:2em;"><a href="E4_PHOS_MET.html">[3] E4_PHOS_MET</a>: Disorders of phosphorus metabolism and phosphatases (ICD-10: E833)<br></span>
<span style="margin-left:2em;"><a href="E4_MG_MET.html">[3] E4_MG_MET</a>: Disorders of magnesium metabolism (ICD-10: E834)<br></span>
<span style="margin-left:2em;"><a href="E4_CA_MET.html">[3] E4_CA_MET</a>: Disorders of calcium metabolism (ICD-10: E835)<br></span>
<span style="margin-left:2em;"><a href="E4_MINERAL_METNAS.html">[3] E4_MINERAL_METNAS</a>: Disorder of mineral metabolism, other/unspecified (ICD-10: E83[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_CYSTFIBRO.html">[C] E4_CYSTFIBRO</a>: Cystic fibrosis (ICD-10: E84)<br></span>
<span style="margin-left:2em;"><a href="E4_CYSFIBRO_PUL.html">[3] E4_CYSFIBRO_PUL</a>: Cystic fibrosis with pulmonary manifestations (ICD-10: E840)<br></span>
<span style="margin-left:2em;"><a href="E4_CYSTFIBRO_INT.html">[3] E4_CYSTFIBRO_INT</a>: Cystic fibrosis with intestinal manifestations (ICD-10: E841)<br></span>
<span style="margin-left:2em;"><a href="E4_CYSTFIBRO_NAS.html">[3] E4_CYSTFIBRO_NAS</a>: Cystic fibrosis, other manifestations/unspecified (ICD-10: E84[8-9])<br></span>
<span style="margin-left:0em;"><a href="E4_AMYLOIDOSIS.html">[C] E4_AMYLOIDOSIS</a>: Amyloidosis (ICD-10: E85)<br></span>
<span style="margin-left:2em;"><a href="E4_AMYL_NONNEURO.html">[3] E4_AMYL_NONNEURO</a>: Non-neuropathic heredofamilial amyloidosis (ICD-10: E850)<br></span>
<span style="margin-left:2em;"><a href="E4_AMYL_NEUROHER.html">[3] E4_AMYL_NEUROHER</a>: Neuropathic heredofamilial amyloidosis (ICD-10: E851)<br></span>
<span style="margin-left:2em;"><a href="E4_AMYL_HEREDOFAM.html">[3] E4_AMYL_HEREDOFAM</a>: Heredofamilial amyloidosis, unspecified (ICD-10: E852)<br></span>
<span style="margin-left:2em;"><a href="E4_AMYL_SCNDSYST.html">[3] E4_AMYL_SCNDSYST</a>: Secondary systemic amyloidosis (ICD-10: E853)<br></span>
<span style="margin-left:2em;"><a href="E4_AMYL_ORGAN.html">[3] E4_AMYL_ORGAN</a>: Organ-limited amyloidosis (ICD-10: E854)<br></span>
<span style="margin-left:2em;"><a href="E4_AMYLNAS.html">[3] E4_AMYLNAS</a>: Amyloidosis, other/unspecified (ICD-10: E85[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_VOLUME.html">[3] E4_VOLUME</a>: Volume depletion (ICD-10: E86)<br></span>
<span style="margin-left:0em;"><a href="E4_FLUIDELECTRO.html">[C] E4_FLUIDELECTRO</a>: Other disorders of fluid, electrolyte and acid-base balance (ICD-10: E87)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPEROSMHNAT.html">[3] E4_HYPEROSMHNAT</a>: Hyperosmolality and hypernatraemia (ICD-10: E870)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOOSMNAT.html">[3] E4_HYPOOSMNAT</a>: Hypo-osmolality and hyponatraemia (ICD-10: E871)<br></span>
<span style="margin-left:2em;"><a href="E4_ACIDOSIS.html">[3] E4_ACIDOSIS</a>: Acidosis (ICD-10: E872)<br></span>
<span style="margin-left:2em;"><a href="E4_ALKALOSIS.html">[3] E4_ALKALOSIS</a>: Alkalosis (ICD-10: E873)<br></span>
<span style="margin-left:2em;"><a href="E4_MIXACIDBASE.html">[3] E4_MIXACIDBASE</a>: Mixed disorder of acid-base balance (ICD-10: E874)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPERKALAEMIA.html">[3] E4_HYPERKALAEMIA</a>: Hyperkalaemia (ICD-10: E875)<br></span>
<span style="margin-left:2em;"><a href="E4_HYPOKALAEMIA.html">[3] E4_HYPOKALAEMIA</a>: Hypokalaemia (ICD-10: E876)<br></span>
<span style="margin-left:2em;"><a href="E4_FLUIDOVER.html">[3] E4_FLUIDOVER</a>: Fluid overload (ICD-10: E877)<br></span>
<span style="margin-left:2em;"><a href="E4_FLUIDELECTRONAS.html">[3] E4_FLUIDELECTRONAS</a>: Other disorders of electrolyte and fluid balance, not elsewhere classified (ICD-10: E878)<br></span>
<span style="margin-left:0em;"><a href="E4_METABO.html">[C] E4_METABO</a>: Other metabolic disorders (ICD-10: E8[8-9]|E90)<br></span>
<span style="margin-left:2em;"><a href="E4_PLASMAPROT.html">[3] E4_PLASMAPROT</a>: Disorders of plasma-protein metabolism, not elsewhere classified (ICD-10: E880)<br></span>
<span style="margin-left:2em;"><a href="E4_LIPODYST.html">[3] E4_LIPODYST</a>: Lipodystrophy, not elsewhere classified (ICD-10: E881)<br></span>
<span style="margin-left:2em;"><a href="E4_LIPOMATOSIS.html">[3] E4_LIPOMATOSIS</a>: Lipomatosis, not elsewhere classified (ICD-10: E882)<br></span>
<span style="margin-left:2em;"><a href="E4_TUMOURLYSISSDR.html">[3] E4_TUMOURLYSISSDR</a>: Tumour lysis syndrome (ICD-10: E883)<br></span>
<span style="margin-left:2em;"><a href="E4_METABONAS.html">[3] E4_METABONAS</a>: Metabolic disorder, other/unspecified (ICD-10: E88[8-9])<br></span>
<span style="margin-left:2em;"><a href="E4_ENDOMETPOSTOP.html">[3] E4_ENDOMETPOSTOP</a>: Postprocedural endocrine and metabolic disorders, not elsewhere classified (ICD-10: E89)<br></span>
<span style="margin-left:2em;"><a href="E4_METABINOTH.html">[3] E4_METABINOTH</a>: Nutritional and metabolic disorders in diseases classified elsewhere (ICD-10: E90)<br></span>
<span style="margin-left:0em;"><a href="E4_OBESITY.html">[C] E4_OBESITY</a>: Obesity (ICD-10: E66)<br></span>
<span style="margin-left:0em;"><a href="E4_DM1.html">[C] E4_DM1</a>: Type 1 diabetes (ICD-10: E10)<br></span>
<span style="margin-left:0em;"><a href="E4_DM1_STRICT.html">[C] E4_DM1_STRICT</a>: Type 1 diabetes, strict (exclude DM2) (ICD-10: E10)<br></span>
<span style="margin-left:0em;"><a href="E4_DM2.html">[C] E4_DM2</a>: Type 2 diabetes (ICD-10: E11)<br></span>
<span style="margin-left:0em;"><a href="E4_DM2_STRICT.html">[C] E4_DM2_STRICT</a>: Type 2 diabetes, strict (exclude DM1) (ICD-10: E11)<br></span>
<span style="margin-left:0em;"><a href="E4_DMICD8.html">[C] E4_DMICD8</a>: Diabetes, unspecified because of ICD-8 (ICD-8: 250)<br></span>
<span style="margin-left:0em;"><a href="E4_DMNAS.html">[C] E4_DMNAS</a>: Unspecified diabetes (ICD-10: E1[2-4])<br></span>
<span style="margin-left:margin-left:0em;;"><a href="DM_COMORB.html">DM_COMORB</a>: Diabetes-related co-morbidities/complications <br></span>
<span style="margin-left:0em;"><a href="E4_PARATHYRO.html">[C] E4_PARATHYRO</a>: Disorders of parathyroid gland (ICD-10: E2[0-1])<br></span>
<span style="margin-left:0em;"><a href="E4_HYPERPIT.html">[C] E4_HYPERPIT</a>: Hyperfunction of pituitary gland (ICD-10: E22)<br></span>
<span style="margin-left:0em;"><a href="E4_ADRENAL.html">[C] E4_ADRENAL</a>: Other disorders of adrenal gland (ICD-10: E27)<br></span>
<span style="margin-left:0em;"><a href="E4_OVARDYS.html">[C] E4_OVARDYS</a>: Ovarian dysfunction (ICD-10: E28)<br></span>
<span style="margin-left:0em;"><a href="E4_TESTIDYS.html">[C] E4_TESTIDYS</a>: Testicular dysfunction (ICD-10: E29)<br></span>
<span style="margin-left:0em;"><a href="E4_DISPUB.html">[C] E4_DISPUB</a>: Disorders of puberty (ICD-10: E30)<br></span>
<span style="margin-left:0em;"><a href="E4_DYSPOLYGL.html">[C] E4_DYSPOLYGL</a>: Polyglandular dysfunction (ICD-10: E31)<br></span>
<span style="margin-left:0em;"><a href="E4_THYMUSDIS.html">[C] E4_THYMUSDIS</a>: Diseases of thymus (ICD-10: E32)<br></span>
<span style="margin-left:0em;"><a href="E4_ENDODIS.html">[C] E4_ENDODIS</a>: Other endocrine disorders (ICD-10: E3[4-5])<br></span>
<span style="margin-left:0em;"><a href="E4_HYPERALI.html">[C] E4_HYPERALI</a>: Other hyperalimentation (ICD-10: E6[7-8])<br></span>
<span style="margin-left:0em;"><a href="E4_AROMAMINO.html">[C] E4_AROMAMINO</a>: Disorders of aromatic amino-acid metabolism (ICD-10: E70)<br></span>
<span style="margin-left:0em;"><a href="E4_BRANCHAMINOFATAC.html">[C] E4_BRANCHAMINOFATAC</a>: Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism (ICD-10: E71)<br></span>
<span style="margin-left:0em;"><a href="E4_AMINO.html">[C] E4_AMINO</a>: Other disorders of amino-acid metabolism (ICD-10: E72)<br></span>
<span style="margin-left:0em;"><a href="E4_LACTOSEINT.html">[C] E4_LACTOSEINT</a>: Lactose intolerance (ICD-10: E73)<br></span>
<span style="margin-left:0em;"><a href="E4_CARBO.html">[C] E4_CARBO</a>: Other disorders of carbohydrate metabolism (ICD-10: E74[0-48-9])<br></span>
<span style="margin-left:0em;"><a href="E4_SPHINGOLIP.html">[C] E4_SPHINGOLIP</a>: Disorders of sphingolipid metabolism and other lipid storage disorders (ICD-10: E75)<br></span>
<span style="margin-left:0em;"><a href="E4_GLYCOSAMINOGLYC.html">[C] E4_GLYCOSAMINOGLYC</a>: Disorders of glycosaminoglycan metabolism (ICD-10: E76)<br></span>
<span style="margin-left:0em;"><a href="E4_GLYCOPROT.html">[C] E4_GLYCOPROT</a>: Disorders of glycoprotein metabolism (ICD-10: E77)<br></span>
<span style="margin-left:0em;"><a href="E4_LIPOPROT.html">[C] E4_LIPOPROT</a>: Disorders of lipoprotein metabolism and other lipidaemias (ICD-10: E78)<br></span>
<span style="margin-left:0em;"><a href="E4_PURINEPYRI.html">[C] E4_PURINEPYRI</a>: Disorders of purine and pyrimidine metabolism (ICD-10: E79)<br></span>
<span style="margin-left:0em;"><a href="E4_PORBILIR.html">[C] E4_PORBILIR</a>: Disorders of porphyrin and bilirubin metabolism (ICD-10: E80)<br></span>
<span style="margin-left:0em;"><a href="E4_MINERAL_MET.html">[C] E4_MINERAL_MET</a>: Disorders of mineral metabolism (ICD-10: E83)<br></span>
<span style="margin-left:0em;"><a href="E4_CYSTFIBRO.html">[C] E4_CYSTFIBRO</a>: Cystic fibrosis (ICD-10: E84)<br></span>
<span style="margin-left:0em;"><a href="E4_AMYLOIDOSIS.html">[C] E4_AMYLOIDOSIS</a>: Amyloidosis (ICD-10: E85)<br></span>
<span style="margin-left:0em;"><a href="E4_FLUIDELECTRO.html">[C] E4_FLUIDELECTRO</a>: Other disorders of fluid, electrolyte and acid-base balance (ICD-10: E87)<br></span>
<span style="margin-left:0em;"><a href="E4_METABO.html">[C] E4_METABO</a>: Other metabolic disorders (ICD-10: E8[8-9]|E90)<br></span>
<span style="margin-left:margin-left:0em;;"><a href="VIT_DEF.html">VIT_DEF</a>: Vitamin deficiency <br></span>
<span style="margin-left:margin-left:margin-left:0em;;;"><a href="C_PSOR_ARTHR_COMORB.html">C_PSOR_ARTHR_COMORB</a>: Psoriatic arthropathies related co-morbidities <br></span>
<address><br>Created by: Aki Havulinna, Tuomo Kiiskinen on 2018-12-04 21:35:26</address>
 </body>
 </html>
